View Future GrowthSAS Florentaise 과거 순이익 실적과거 기준 점검 0/6지난 몇 년간 SAS Florentaise 의 실적에 대한 데이터가 부족합니다.핵심 정보n/a순이익 성장률n/a주당순이익(EPS) 성장률Chemicals 산업 성장률12.41%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Jun 2024최근 과거 실적 업데이트Reported Earnings • Mar 31First half 2024 earnings releasedFirst half 2024 results: €0.28 loss per share. Net loss: €2.27m (flat on 1H 2023).Reported Earnings • Nov 02Full year 2023 earnings released: EPS: €0.07 (vs €0.49 in FY 2022)Full year 2023 results: EPS: €0.07 (down from €0.49 in FY 2022). Revenue: €54.5m (down 14% from FY 2022). Net income: €562.0k (down 80% from FY 2022). Profit margin: 1.0% (down from 4.5% in FY 2022).모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • May 17SAS Florentaise, Annual General Meeting, Jun 20, 2025SAS Florentaise, Annual General Meeting, Jun 20, 2025. Location: grand patis, saint mars du desert FranceReported Earnings • Mar 31First half 2024 earnings releasedFirst half 2024 results: €0.28 loss per share. Net loss: €2.27m (flat on 1H 2023).Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €2.32, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 13x in the Chemicals industry in Germany.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €1.89, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 12x in the Chemicals industry in Germany.New Risk • Nov 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Revenue has declined by 16% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (€24.6m market cap, or US$26.3m).Valuation Update With 7 Day Price Move • Nov 07Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to €3.86, the stock trades at a trailing P/E ratio of 56.9x. Average trailing P/E is 11x in the Chemicals industry in Germany.Reported Earnings • Nov 02Full year 2023 earnings released: EPS: €0.07 (vs €0.49 in FY 2022)Full year 2023 results: EPS: €0.07 (down from €0.49 in FY 2022). Revenue: €54.5m (down 14% from FY 2022). Net income: €562.0k (down 80% from FY 2022). Profit margin: 1.0% (down from 4.5% in FY 2022).New Risk • Sep 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€54.0m market cap, or US$57.6m).New Risk • Sep 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€61.2m market cap, or US$65.6m).Board Change • May 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역SAS Florentaise가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:QR0 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비30 Jun 2467012031 Mar 2463012031 Dec 2359012030 Sep 2356012030 Jun 2353111030 Jun 226339030 Jun 215939030 Jun 2044170양질의 수익: QR0가 고품질 수익을 갖고 있는지 판단하기에는 데이터가 부족합니다.이익 마진 증가: 지난 1년 동안 QR0의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 QR0의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: QR0의 지난해 수익 성장률을 5년 평균과 비교하기에 데이터가 부족합니다.수익 대 산업: QR0의 지난 해 수익 증가율이 Chemicals 업계 평균을 상회했는지 판단하기에 데이터가 부족합니다.자기자본이익률높은 ROE: QR0는 현재 수익성이 없으므로 자본 수익률이 음수(0%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 17:28종가2026/05/22 00:00수익2024/06/30연간 수익2024/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스SAS Florentaise는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Mar 31First half 2024 earnings releasedFirst half 2024 results: €0.28 loss per share. Net loss: €2.27m (flat on 1H 2023).
Reported Earnings • Nov 02Full year 2023 earnings released: EPS: €0.07 (vs €0.49 in FY 2022)Full year 2023 results: EPS: €0.07 (down from €0.49 in FY 2022). Revenue: €54.5m (down 14% from FY 2022). Net income: €562.0k (down 80% from FY 2022). Profit margin: 1.0% (down from 4.5% in FY 2022).
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • May 17SAS Florentaise, Annual General Meeting, Jun 20, 2025SAS Florentaise, Annual General Meeting, Jun 20, 2025. Location: grand patis, saint mars du desert France
Reported Earnings • Mar 31First half 2024 earnings releasedFirst half 2024 results: €0.28 loss per share. Net loss: €2.27m (flat on 1H 2023).
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €2.32, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 13x in the Chemicals industry in Germany.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €1.89, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 12x in the Chemicals industry in Germany.
New Risk • Nov 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Revenue has declined by 16% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (€24.6m market cap, or US$26.3m).
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to €3.86, the stock trades at a trailing P/E ratio of 56.9x. Average trailing P/E is 11x in the Chemicals industry in Germany.
Reported Earnings • Nov 02Full year 2023 earnings released: EPS: €0.07 (vs €0.49 in FY 2022)Full year 2023 results: EPS: €0.07 (down from €0.49 in FY 2022). Revenue: €54.5m (down 14% from FY 2022). Net income: €562.0k (down 80% from FY 2022). Profit margin: 1.0% (down from 4.5% in FY 2022).
New Risk • Sep 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€54.0m market cap, or US$57.6m).
New Risk • Sep 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€61.2m market cap, or US$65.6m).
Board Change • May 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.